Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis.

Mei-Xuan LiYan-Fei LiXin XingJun-Qiang NiuLiang YaoMeng-Ying LuKe GuoMi-Na MaXiao-Tian WuNing MaDan LiZi-Jun LiLing GuanXiao-Man WangBei PanWen-Ru ShangJing JiZhong-Yang SongZhi-Ming ZhangYong-Feng WangKe-Hu Yang

Published in: Inflammopharmacology (2023)

Very low to moderate certainty of evidence indicated IVIg may not improve the clinical outcomes of hospitalized patients with COVID-19. Given the discrepancy between the random- and fixed-effects model results, further large-scale and well-designed RCTs are warranted.

Keyphrases

sars cov
high resolution
high dose
high intensity
combination therapy
mass spectrometry